Crossmark

Discovery of quinazoline-2,4(1<i>H</i>,3<i>H</i>)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity

Crossref DOI link: https://doi.org/10.1039/C8OB00286J

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Zhou, Jie

Ji, Ming

Yao, Haiping

Cao, Ran

Zhao, Hailong

Wang, Xiaoyu

Chen, Xiaoguang

Xu, Bailing https://orcid.org/0000-0003-2633-0887
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81673300)

Chinese Academy of Medical Sciences (CAMS-I2M-2-004)
License Information

Accepted Manuscript valid from 2019-04-06
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Bailing Xu (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 3 February 2018; Accepted 5 April 2018; Accepted Manuscript published 6 April 2018; Advance Article published 12 April 2018; Version of Record published 2 May 2018